Neville Rodie & Shaw’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-33,012
| Closed | -$5.85M | – | 245 |
|
|
2020
Q1 | $5.85M | Hold |
33,012
| – | – | 0.71% | 48 |
|
|
2019
Q4 | $6.31M | Sell |
33,012
-5,625
| -15% | -$1.08M | 0.62% | 49 |
|
|
2019
Q3 | $6.5M | Hold |
38,637
| – | – | 0.69% | 45 |
|
|
2019
Q2 | $6.47M | Sell |
38,637
-11,065
| -22% | -$1.85M | 0.68% | 47 |
|
|
2019
Q1 | $7.28M | Hold |
49,702
| – | – | 0.77% | 42 |
|
|
2018
Q4 | $6.64M | Sell |
49,702
-4,900
| -9% | -$655K | 0.81% | 40 |
|
|
2018
Q3 | $10.4M | Sell |
54,602
-2,700
| -5% | -$514K | 1.03% | 30 |
|
|
2018
Q2 | $9.55M | Buy |
57,302
+55,287
| +2,744% | +$9.22M | 1.01% | 32 |
|
|
2018
Q1 | $339K | Buy |
2,015
+46
| +2% | +$7.74K | 0.04% | 195 |
|
|
2017
Q4 | $322K | Sell |
1,969
-830
| -30% | -$136K | 0.03% | 200 |
|
|
2017
Q3 | $574K | Buy |
2,799
+100
| +4% | +$20.5K | 0.06% | 155 |
|
|
2017
Q2 | $656K | Sell |
2,699
-375
| -12% | -$91.1K | 0.07% | 153 |
|
|
2017
Q1 | $734K | Buy |
3,074
+305
| +11% | +$72.8K | 0.08% | 149 |
|
|
2016
Q4 | $581K | Sell |
2,769
-12,740
| -82% | -$2.67M | 0.07% | 159 |
|
|
2016
Q3 | $3.57M | Buy |
15,509
+170
| +1% | +$39.1K | 0.42% | 74 |
|
|
2016
Q2 | $3.54M | Sell |
15,339
-1,360
| -8% | -$314K | 0.42% | 73 |
|
|
2016
Q1 | $4.48M | Buy |
16,699
+800
| +5% | +$214K | 0.54% | 65 |
|
|
2015
Q4 | $4.97M | Buy |
15,899
+75
| +0.5% | +$23.4K | 0.6% | 60 |
|
|
2015
Q3 | $4.3M | Sell |
15,824
-9
| -0.1% | -$2.45K | 0.53% | 61 |
|
|
2015
Q2 | $4.81M | Sell |
15,833
-330
| -2% | -$100K | 0.53% | 62 |
|
|
2015
Q1 | $4.81M | Buy |
16,163
+3,450
| +27% | +$1.03M | 0.5% | 67 |
|
|
2014
Q4 | $3.27M | Buy |
12,713
+7,010
| +123% | +$1.8M | 0.33% | 83 |
|
|
2014
Q3 | $1.38M | Buy |
+5,703
| New | +$1.38M | 0.14% | 117 |
|